Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis-Reference-Cited by-同舟云学术

Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis

Published:2019-05-24 Issue:11 Volume:34 Page:1839-1851
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Sakuma Ichiro,Uchiyama Shinichiro,Atarashi Hirotsugu,Inoue Hiroshi,Kitazono Takanari,Yamashita Takeshi,Shimizu Wataru,Ikeda Takanori,Kamouchi Masahiro,Kaikita Koichi,Fukuda Koji,Origasa Hideki,Shimokawa Hiroaki^ORCID

Funder

Bayer Yakuhin Ltd

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-019-01425-x.pdf

Reference26 articles.

1. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S (2009) Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 137:102–107

2. Sakamoto T, Inoue H (2013) Epidemiology and prognosis of atrial fibrillation in Japanese population. Nihon Rinsho 71:15–20 (in Japanese)

3. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870

4. Suzuki S, Yamashita T, Okumura K, Atarashi H, Akao M, Ogawa H, Inoue H (2015) Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy–pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 79:432–438

5. Inoue H, Nozawa T, Hirai T, Iwasa A, Okumura K, Lee JD, Shimizu A, Hayano M, Yano K (2006) Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation. Circ J 70:651–656

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial Fibrillation;Journal of Clinical Medicine;2024-04-15

2. External Validation of COOL-AF Scores in the Asian Pacific Heart Rhythm Society Atrial Fibrillation Registry;JACC: Asia;2024-01

3. XGBoost-based machine learning test improves the accuracy of hemorrhage prediction among geriatric patients with long-term administration of rivaroxaban;BMC Geriatrics;2023-07-10

4. Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review;Blood Coagulation & Fibrinolysis;2023-06-09

5. New score for predicting major bleeding in patients with atrial fibrillation using direct oral anticoagulants;International Journal of Cardiology;2023-04